Stability Study of Cannabidiol in the Form of Solid Powder and Sunflower Oil Solution

Stability Study of Cannabidiol in the Form of Solid Powder and Sunflower Oil Solution

Stability studies represent an essential component of pharmaceutical development, enabling critical evaluation of the therapeutic potential of an active pharmaceutical ingredient (API) or a final pharmaceutical product under the influence of various environmental factors. The aim of the present stud...

Full description

Bibliographic Details
Main Authors:	Ema Kosović, David Sýkora, Martin Kuchař
Format:	Article
Language:	English
Published:	MDPI AG 2021-03-01
Series:	Pharmaceutics
Subjects:	cannabidiol degradation oil matrix stability study tetrahydrocannabinol cannabinol
Online Access:	https://www.mdpi.com/1999-4923/13/3/412

Similar Items

The content of basic cannabinoids and their mutual ratios in Cannabis sativa L. plant
by: Dragoljić Mirjana M., et al.
Published: (2019-01-01)

Microwave-Assisted Extraction of Cannabinoids in Hemp Nut Using Response Surface Methodology: Optimization and Comparative Study
by: Chih-Wei Chang, et al.
Published: (2017-11-01)

Pharmacokinetics of Cannabidiol, Cannabidiolic Acid, Δ9-Tetrahydrocannabinol, Tetrahydrocannabinolic Acid and Related Metabolites in Canine Serum After Dosing With Three Oral Forms of Hemp Extract
by: Joseph J. Wakshlag, et al.
Published: (2020-09-01)

ESTUDIO DEL CONTENIDO DE CANABINOIDES EN MUESTRAS DE MARIHUANA (Cannabis sativa L.) CULTIVADAS EN VARIAS REGIONES DE COLOMBIA STUDY OF CANNABINOIDS CONTENT IN MARIHUANA SAMPLES (Cannabis sativa L.) CULTIVATED IN SEVERAL REGIONS OF COLOMBIA
by: Néstor M FLORIAN R, et al.
Published: (2009-05-01)

Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01)

Analysis of Cannabidiol, Δ9-Tetrahydrocannabinol, and Their Acids in CBD Oil/Hemp Oil Products
by: Mahmoud A. ElSohly, et al.
Published: (2020-08-01)

A Quantitative <sup>1</sup>H NMR Method for Screening Cannabinoids in CBD Oils
by: Ines Barthlott, et al.
Published: (2021-06-01)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
by: Patricia Golombek, et al.
Published: (2020-06-01)

A pharmacological characterization of Cannabis sativa chemovar extracts
by: Alykhan Devsi, et al.
Published: (2020-05-01)

Δ 9-Tetrahydrocannabinol Toxicity and Validation of Cannabidiol on Brain Dopamine Levels: An Assessment on Cannabis Duplicity
by: Swapnali Chetia, et al.
Published: (2020-08-01)

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug
by: Zuardi A.W., et al.
Published: (2006-01-01)

The Impact of Cannabidiol on Human Brain Function: A Systematic Review
by: Albert Batalla, et al.
Published: (2021-01-01)

Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)
by: Thomas Meyer, et al.
Published: (2019-09-01)

Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
by: Timo Woelfl, et al.
Published: (2020-11-01)

Efficacy of Δ9 -Tetrahydrocannabinol (THC) Alone or in Combination With a 1:1 Ratio of Cannabidiol (CBD) in Reversing the Spatial Learning Deficits in Old Mice
by: Prakash Nidadavolu, et al.
Published: (2021-08-01)

Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
by: Paul T. Kocis, et al.
Published: (2020-07-01)

Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study
by: Richard J. Huntsman, et al.
Published: (2019-07-01)

Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer
by: Golnaz Sharafi, et al.
Published: (2019-01-01)

An Update of Current Cannabis-Based Pharmaceuticals in Pain Medicine
by: Ivan Urits, et al.
Published: (2019-02-01)

The role of cannabinoids and endocannabinoid system in the treatment of epilepsy
by: Pędracka Monika, et al.
Published: (2015-12-01)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
by: Francesco Bartoli, et al.
Published: (2021-03-01)

Propagation of Cannabis for Clinical Research: An Approach Towards a Modern Herbal Medicinal Products Development
by: Suman Chandra, et al.
Published: (2020-06-01)

Priority areas for cannabis and cannabinoid product research in South Africa
by: Tanya N. Augustine, et al.
Published: (2018-06-01)

Industrial, CBD, and Wild Hemp: How Different Are Their Essential Oil Profile and Antimicrobial Activity?
by: Valtcho D. Zheljazkov, et al.
Published: (2020-10-01)

Duration of Neurocognitive Impairment With Medical Cannabis Use: A Scoping Review
by: Lauren Eadie, et al.
Published: (2021-03-01)

Safety Considerations in Cannabinoid-Based Medicine
by: Gottschling S, et al.
Published: (2020-12-01)

Characteristics of Older Adults Who Were Early Adopters of Medical Cannabis in the Florida Medical Marijuana Use Registry
by: Joshua D. Brown, et al.
Published: (2020-04-01)

New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
by: Maria Scherma, et al.
Published: (2018-10-01)

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
by: Erin L. Martin, et al.
Published: (2021-09-01)

A Review on Agronomic, Phytochemical and Pharmacological Aspects of Cannabis (Cannabis sativa L.)
by: S Asadi, et al.
Published: (2019-05-01)

Preliminary Study: Comparison of Antioxidant Activity of Cannabidiol (CBD) and α-Tocopherol Added to Refined Olive and Sunflower Oils
by: Matilde Tura, et al.
Published: (2019-09-01)

Grinding and Fractionation during Distillation Alter Hemp Essential Oil Profile and Its Antimicrobial Activity
by: Valtcho D. Zheljazkov, et al.
Published: (2020-08-01)

Potential impacts of soil microbiota manipulation on secondary metabolites production in cannabis
by: Bulbul Ahmed, et al.
Published: (2021-07-01)

A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics
by: Kevin P. Hill, et al.
Published: (2021-07-01)

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
by: Arun Bhaskar, et al.
Published: (2021-07-01)

Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
by: Tamara T. Lah, et al.
Published: (2021-02-01)

The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
by: Ewgeni Jakubovski, et al.
Published: (2020-11-01)

Investigating Relationships Between Alcohol and Cannabis Use in an Online Survey of Cannabis Users: A Focus on Cannabinoid Content and Cannabis for Medical Purposes
by: Hollis C. Karoly, et al.
Published: (2020-12-01)

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
by: Marco Colizzi, et al.
Published: (2020-05-01)

Cannabinoids and centrak neuropathic pain. A review (Cannabinoidi e dolore neuropatico centrale. Una rassegna)
by: Francesco Crestani
Published: (2014-03-01)